These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1296146)

  • 1. [Microvascular complications in diabetes mellitus. Pathogenetic aspects].
    Andronico G; Cerasola G
    Minerva Endocrinol; 1992; 17(2):67-73. PubMed ID: 1296146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
    Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
    Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive treatment of diabetic microangiopathy: blocking the pathogenic mechanisms].
    Guillausseau PJ
    Diabete Metab; 1994; 20(2 Pt 2):219-28. PubMed ID: 8001709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of microangiopathy in type 1 diabetes mellitus. A review.
    Borch-Johnsen K
    Diabete Metab; 1993; 19(1 Pt 2):133-7. PubMed ID: 8314416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic microvascular complications: can patients at risk be identified? A review.
    Girach A; Manner D; Porta M
    Int J Clin Pract; 2006 Nov; 60(11):1471-83. PubMed ID: 17073842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic microvascular complications--can the presence of one predict the development of another?
    Girach A; Vignati L
    J Diabetes Complications; 2006; 20(4):228-37. PubMed ID: 16798474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in diabetes for the millennium: chronic microvascular complications of diabetes.
    Olansky L
    MedGenMed; 2004 Aug; 6(3 Suppl):14. PubMed ID: 15647719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.
    Orchard TJ; Forrest KY; Ellis D; Becker DJ
    Arch Intern Med; 1997 Sep; 157(16):1851-6. PubMed ID: 9290544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes mellitus: the role of metabolic control in the prevention of complications].
    Gomez F; Chabot V
    Schweiz Med Wochenschr; 1983 Sep; 113(38):1342-5. PubMed ID: 6415812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
    Viberti G
    J Diabetes Complications; 2005; 19(3):168-77. PubMed ID: 15866064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering?
    Leiter LA
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S3-14. PubMed ID: 15953505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of long-term complications of non-insulin-dependent diabetes mellitus.
    Nathan DM
    Clin Invest Med; 1995 Aug; 18(4):332-9. PubMed ID: 8549021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes.
    Groop PH; Forsblom C; Thomas MC
    Nat Clin Pract Endocrinol Metab; 2005 Dec; 1(2):100-10. PubMed ID: 16929378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients.
    Cardoso CR; Salles GF
    J Diabetes Complications; 2008; 22(3):164-70. PubMed ID: 18413219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Lipoproteins, glycoxidation and diabetic angiopathy'.
    Jenkins AJ; Best JD; Klein RL; Lyons TJ
    Diabetes Metab Res Rev; 2004; 20(5):349-68. PubMed ID: 15343582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of microvascular and macrovascular complications in diabetes mellitus.
    Maji D
    J Indian Med Assoc; 2004 Aug; 102(8):426, 428, 430 passim. PubMed ID: 15719805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of microangiopathy in growth-onset diabetes. With special reference to retinopathy and glycaemic control.
    Sterky G; Wall S
    Acta Paediatr Scand Suppl; 1986; 327():1-45. PubMed ID: 3494378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.